Search
Patexia Research
Case number 1:11-cv-00239

Abbott Laboratories et al v. Teva Pharmaceutical Industries Ltd. et al > Summary

Court Case Number 1:11-cv-00239

Filing Date Mar 21, 2011

Termination Date Jan 3, 2012

Court Delaware District Court

Status Unknown

Plaintiff

2

Abbott Laboratories

Abbott Respiratory Llc

Defendant

Teva Pharmaceuticals

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
07011848 Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor Mar 14, 2006
06818229 Intermediate release nicotinic acid compositions for treating hyperlipidemia Nov 16, 2004
06746691 Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics Jun 8, 2004
06676967 Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia Jan 13, 2004
06469035 Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid Oct 22, 2002
06406715 Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles Jun 18, 2002
06129930 Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night Oct 10, 2000
06080428 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor Jun 27, 2000
Menu